11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Autor: Rinne, Juha O, Brooks, David J, Rossor, Martin N, Fox, Nick C, Bullock, Roger, Klunk, William E, Mathis, Chester A, Blennow, Kaj, Barakos, Jerome, Okello, Aren A, de LIano, Sofia Rodriguez Martinez, Liu, Enchi, Koller, Martin, Gregg, Keith M, Schenk, Dale, Black, Ronald, Grundman, Michael
Zdroj: In Lancet Neurology 2010 9(4):363-372
Databáze: ScienceDirect